EHWM
GSK icon

Eads & Heald Wealth Management’s GSK GSK Stock Holding History

Eads & Heald Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,971
Closed -$219K – 151
2026
Q1 		$219K Sell
3,971
-320
-7% -$17.3K 0.11% 140
2025
Q4 		$210K Buy
+4,291
New +$200K 0.1% 139
2022
Q3 		– Sell
-4,756
Closed -$259K – 148
2022
Q2 		$259K Sell
4,756
-4
-0.1% -$221 0.14% 137
2022
Q1 		$259K Sell
4,760
-7
-0.1% -$380 0.12% 133
2021
Q4 		$263K Buy
4,767
+117
+3% +$6.09K 0.11% 137
2021
Q3 		$222K Buy
+4,650
New +$234K 0.11% 138
2017
Q4 		– Sell
-4,998
Closed -$254K – 130
2017
Q3 		$254K Sell
4,998
-19
-0.4% -$964 0.16% 120
2017
Q2 		$270K Sell
5,017
-2
-0% -$107 0.17% 119
2017
Q1 		$265K Sell
5,019
-460
-8% -$23.3K 0.17% 117
2016
Q4 		$264K Sell
5,479
-240
-4% -$11.9K 0.18% 118
2016
Q3 		$308K Buy
5,719
+36
+0.6% +$1.97K 0.21% 117
2016
Q2 		$308K Sell
5,683
-48
-0.8% -$2.53K 0.21% 115
2016
Q1 		$291K Buy
5,731
+154
+3% +$7.67K 0.2% 118
2015
Q4 		$281K Sell
5,577
-1,936
-26% -$98.7K 0.19% 122
2015
Q3 		$361K Sell
7,513
-392
-5% -$20.4K 0.26% 115
2015
Q2 		$412K Buy
7,905
+692
+10% +$39K 0.27% 112
2015
Q1 		$416K Buy
7,213
+300
+4% +$17.2K 0.27% 110
2014
Q4 		$369K Buy
+6,913
New +$387K 0.23% 110
2014
Q3 		– Sell
-3,413
Closed -$228K – 125
2014
Q2 		$228K Buy
3,413
+45
+1% +$3.05K 0.15% 113
2014
Q1 		$225K Buy
+3,368
New +$228K 0.15% 112

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Eads & Heald Wealth Management's GSK Position: Q2 2026 in Review

Eads & Heald Wealth Management sold out of GSK (GSK) in Q2 2026, closing a stake of 3,971 shares — an estimated $219K sold.

Eads & Heald Wealth Management first reported a position in GSK in Q1 2014 and held it in 20 quarters. The position peaked at $416K in Q1 2015. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Eads & Heald Wealth Management reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Eads & Heald Wealth Management sold 3,971 GSK shares in Q2 2026, an estimated $219K.
  • Eads & Heald Wealth Management first reported a position in GSK in Q1 2014 and held it in 20 quarters.
  • Eads & Heald Wealth Management's GSK position peaked at $416K in Q1 2015.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Eads & Heald Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.